Cargando…

Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide

BACKGROUND: Randomized controlled trials indicate that addition of a long-acting muscarinic antagonist (LAMA) such as tiotropium may improve asthma control and reduce exacerbation risk in patients with poorly controlled asthma, but broader clinical studies are needed to investigate the effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales:	Price, David, Kaplan, Alan, Jones, Rupert, Freeman, Daryl, Burden, Anne, Gould, Shuna, von Ziegenweidt, Julie, Ali, Muzammil, King, Christine, Thomas, Mike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298307/ https://www.ncbi.nlm.nih.gov/pubmed/25609985 http://dx.doi.org/10.2147/JAA.S76639

Ejemplares similares

Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium
por: Hamelmann, Eckard
Publicado: (2018)

Corrigendum to “Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium”
por: Hamelmann, Eckard
Publicado: (2019)

Tiotropium bromide
por: Lipson, David A
Publicado: (2006)

Expression of Muscarinic Receptors and the Effect of Tiotropium Bromide in Aged Mouse Model of Chronic Asthma
por: Kang, Ji Young, et al.
Publicado: (2019)

Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
por: Busse, William W., et al.
Publicado: (2016)

Tiotropium Bromide: An Update
por: Heredia, Josep Lluis
Publicado: (2009)

Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care
por: Price, David, et al.
Publicado: (2013)

Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD
por: D’Urzo, Anthony D, et al.
Publicado: (2018)

Inhibition of granulocyte migration by tiotropium bromide
por: Vacca, Gabriela, et al.
Publicado: (2011)

Therapeutic Effects of a Long-Acting Cholinergic Receptor Blocker, Tiotropium Bromide, on Asthma
por: Zhang, Li, et al.
Publicado: (2018)

A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study
por: Chapman, Kenneth R, et al.
Publicado: (2014)

Novel long‐acting antagonists of muscarinic ACh receptors
por: Randáková, Alena, et al.
Publicado: (2018)

Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma
por: Aalbers, René, et al.
Publicado: (2017)

The evidence on tiotropium bromide in asthma: from the rationale to the bedside
por: Radovanovic, Dejan, et al.
Publicado: (2017)

Efficacy and safety of muscarinic antagonists as add-on therapy for male lower urinary tract symptoms
por: Li, Jinhong, et al.
Publicado: (2014)

Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit
por: Ulrik, Charlotte Suppli
Publicado: (2012)

Effect of add-on therapy of tiotropium in COPD treated with theophylline
por: Kawayama, Tomotaka, et al.
Publicado: (2008)

Skin reaction to inhaled tiotropium bromide: a case report
por: Incorvaia, Cristoforo, et al.
Publicado: (2011)

Tiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial Asthma
por: Alvarado-Gonzalez, Alcibey, et al.
Publicado: (2015)

Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside
por: Radovanovic, Dejan, et al.
Publicado: (2017)

Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?
por: Cazzola, Mario, et al.
Publicado: (2023)

Small airways ventilation heterogeneity and hyperinflation in COPD: Response to tiotropium bromide
por: Verbanck, Sylvia, et al.
Publicado: (2007)

Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers
por: Algorta, Jaime, et al.
Publicado: (2016)

Tiotropium bromide as adjunct therapy in children with asthma: a clinical experience
por: Ridha, Zainab, et al.
Publicado: (2021)

Tiotropium in the add-on treatment of asthma in adults: clinical trial evidence and experience
por: Vogelberg, Christian
Publicado: (2016)

Tiotropium as an Add-on Treatment Option for Severe Uncontrolled Asthma in Preschool Patients
por: Zielen, Stefan, et al.
Publicado: (2021)

Efficacy and safety of tiotropium in COPD patients in primary care – the SPiRiva Usual CarE (SPRUCE) study
por: Freeman, Daryl, et al.
Publicado: (2007)

Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium
por: Katsumata, Mineo, et al.
Publicado: (2022)

Suppression of IL-8 production from airway cells by tiotropium bromide in vitro
por: Suzaki, Isao, et al.
Publicado: (2011)

Use of tiotropium bromide in an adolescent with adrenal suppression secondary to inhaled mometasone furoate
por: Hanna, Mariam, et al.
Publicado: (2014)

Tiotropium Bromide Improves Neutrophilic Asthma by Recovering Histone Deacetylase 2 Activity
por: An, Tai Joon, et al.
Publicado: (2023)

Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan
por: Yamada, Hideyasu, et al.
Publicado: (2018)

Investigating the Unbinding of Muscarinic Antagonists from the Muscarinic 3 Receptor
por: Buigues, Pedro J., et al.
Publicado: (2023)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

A comparison of tiotropium, long-acting β(2)-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma
por: Vogelberg, Christian, et al.
Publicado: (2020)

Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients
por: Price, David, et al.
Publicado: (2014)

Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients
por: Vogelberg, Christian, et al.
Publicado: (2019)

Long-acting muscarinic antagonists for the treatment of asthma in children—a new kid in town
por: Hamelmann, Eckard
Publicado: (2018)

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease
por: Ora, Josuel, et al.
Publicado: (2020)

Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro
por: Asano, Kazuhito, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_12pfu8tp59f5qr0jeguc1cljcb